1.Temporary homonymous hemianopsia after epidural blood patch.
Hyeonkyeong YEON ; Young Ok SHIN ; Oh Young LEE ; Eunjeong KWON ; Eun Hwan JEONG
Obstetrics & Gynecology Science 2013;56(2):130-133
We describe a case in which homonymous hemianopsia developed abruptly following an epidural blood patch procedure. The procedure was performed in a patient complaining of post-dural puncture headache after an emergency Cesarean section under spinal anesthesia. Computed tomography and magnetic resonance imaging demonstrated that air bubbles had moved from the prepontine and premedullar cisterns toward the left retrochiasmal region. The homonymous hemianopsia resolved rapidly with conservative management including oxygen, intravenous fluid, and antibiotics. We report on this case with a brief review of the related literature.
Anesthesia, Spinal
;
Anti-Bacterial Agents
;
Blood Patch, Epidural
;
Cesarean Section
;
Emergencies
;
Female
;
Hemianopsia
;
Humans
;
Magnetic Resonance Imaging
;
Oxygen
;
Pneumocephalus
;
Post-Dural Puncture Headache
;
Pregnancy
2.Multicystic benign mesothelioma of the pelvic peritoneum presenting as acute abdominal pain in a young woman.
Jung Hee HONG ; Seob JEON ; Ji Hye LEE ; Kye Hyun NAM ; Dong Han BAE
Obstetrics & Gynecology Science 2013;56(2):126-129
Multicystic benign mesothelioma (MBM) of the peritoneum is a very rare condition. Since the first description of MBM in 1979, approximately 100 cases have been reported. This is a case report of MBM of the pelvic peritoneum presenting as acute abdominal pain in a young woman. Laparoscopy confirmed multiple grapelike clusters of cysts that originated in the peritoneum of the rectouterine pouch and histopathologic diagnosis was confirmed as MBM of the pelvic peritoneum. We hope to alert gynaecologists of the diagnostic and therapeutic approaches to MBM which can be accomplished by laparoscopy.
Abdominal Pain
;
Douglas' Pouch
;
Female
;
Humans
;
Laparoscopy
;
Mesothelioma
;
Peritoneum
3.Squamous cell carcinoma arising in an ovarian mature cystic teratoma complicating pregnancy.
Nae Ri YUN ; Jung Woo PARK ; Min Kyung HYUN ; Jee Hyun PARK ; Suk Jin CHOI ; Eunseop SONG
Obstetrics & Gynecology Science 2013;56(2):121-125
Mature cystic teratomas of the ovary (MCT) are usually observed in women of reproductive age with the most dreadful complication being malignant transformation which occurs in approximately 1% to 3% of MCTs. In this case report, we present a patient with squamous cell carcinoma which developed from a MCT during pregnancy. The patient was treated conservatively without adjuvant chemotherapy and was followed without evidence of disease for more than 60 months using conventional tools as well as positron emission tomography-computed tomography following the initial surgery. We report this case along with the review of literature.
Carcinoma, Squamous Cell
;
Chemotherapy, Adjuvant
;
Dermoid Cyst
;
Electrons
;
Female
;
Humans
;
Ovary
;
Pregnancy
;
Teratoma
4.Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women.
Min Jeong KIM ; Jin Ju KIM ; Sunmie KIM
Obstetrics & Gynecology Science 2013;56(2):110-120
OBJECTIVE: We investigated the type-specific high-risk human papillomavirus (HPV) prevalence and distribution according to cervical cytology and age in healthy Korean women. METHODS: A retrospective cross-sectional study was conducted with 7,014 consecutive subjects undergoing both liquid-based cervical cytology and HPV genotyping test by DNA chip for cervical cancer screening. The type-specific prevalence and distribution of individual high-risk HPV types were assessed according to cervical cytology and age groups (<30, 30-39, 40-49, 50-59, and > or =60 years old). RESULTS: In total, the most common HPV genotype was HPV58 (23.9% of all high-risk HPV-positive subjects), followed by HPV16 (21.8%), HPV52 (16.6%), and HPV18 (11.7%). Regarding cervical cytology and age groups, the proportion of HPV56 strongly increased with the increasing severity of cervical cytology (P for trend=0.041). An age-specific decline in the overall high-risk HPV prevalence was reaffirmed, and the proportion of HPV52 declined markedly with age (P for trend=0.014). CONCLUSION: The type-specific prevalence of high-risk HPV types significantly varies according to cervical cytology and age. It may imply that these types have different to develop into precancerous lesions in normal cervix.
Cervix Uteri
;
Cross-Sectional Studies
;
Female
;
Genotype
;
Humans
;
Mass Screening
;
Oligonucleotide Array Sequence Analysis
;
Prevalence
;
Retrospective Studies
;
Uterine Cervical Neoplasms
5.Expression of CD44 in endometrial stromal cells from women with and without endometriosis and its effect on the adherence to peritoneal mesothelial cells.
Yun Hee KOO ; Yong Jin NA ; Mee Young AHN ; Han Na JEON ; Jung In YEOM ; Kyu Sup LEE
Obstetrics & Gynecology Science 2013;56(2):102-109
OBJECTIVE: This study was performed to compare the expression of CD44 in endometrial stromal cells (ESCs) of women with and without endometriosis and to evaluate the role of CD44 in the adherence of ESCs to peritoneal mesothelial cells (PMCs). METHODS: A PMC adherence assay was performed to evaluate the adherence of ESCs to PMCs in women with and without endometriosis. The expression of CD44 mRNA was measured by reverse transcription-polymerase chain reaction. CD44 protein was evaluated by Western blot analysis. RESULTS: There were no significant differences in the expression of CD44 mRNA and protein in ESCs or in the binding of ESCs to PMCs between patients with endometriosis and controls. Although the expression of CD44 protein was decreased in both women with endometriosis and controls after anti-CD44 antibody treatment, there was no effect on binding of ESCs to PMCs. Treatment of ESCs with peritoneal fluid from endometriosis patients resulted in a significant increase in binding of ESCs to PMCs compared to untreated ESCs in the endometriosis group. CONCLUSION: This study demonstrates that the expression of CD44 protein in ESCs from women with endometriosis might not be directly associated with adherence to PMCs.
Ascitic Fluid
;
Blotting, Western
;
Endometriosis
;
Female
;
Humans
;
RNA, Messenger
;
Stromal Cells
6.The ON-Q pain management system in elective gynecology oncologic surgery: Management of postoperative surgical site pain compared to intravenous patient-controlled analgesia.
Dawn CHUNG ; Yoo Jin LEE ; Mi Hyun JO ; Hyun Jong PARK ; Ga Won LIM ; Hanbyoul CHO ; Eun Ji NAM ; Sang Wun KIM ; Jae Hoon KIM ; Young Tae KIM ; Sunghoon KIM
Obstetrics & Gynecology Science 2013;56(2):93-101
OBJECTIVE: The goal of this study was to compare postoperative surgical site pain in gynecologic cancer patients who underwent elective extended lower midline laparotomy and managed their pain with either the ON-Q pain management system (surgical incision site pain relief system, ON-Q pump) or an intravenous patient-controlled analgesia pump (IV PCA). METHODS: Twenty gynecologic cancer patients who underwent elective extended lower midline laparotomy were divided into two groups. One group received a 72-hour continuous wound perfusion of the local anesthetic ropivacaine (0.5%, study group) into the supraperitoneal layer of the abdominal incision through the ON-Q pump. The other group received intravenous infusion pump of patient-controlled analgesia (fentanyl citrate 20 mg/mL . kg+ondansetron hydrochloride 16 mg/8 mL+normal saline). Postoperative pain was assessed immediately and at 6, 24, 48, 72, and 96 hours after surgery using the visual analogue scale. RESULTS: Postoperative surgical site pain scores at 24, 48, and 72 hours after surgery were lower in the ON-Q group than the IV PCA group. Pain scores at 24 hours and 48 hours after surgery were significantly different between the two groups (P=0.023, P<0.001). Overall painkiller administration was higher in the ON-Q group but this difference was not statistically significant (5.1 vs. 4.3, P=0.481). CONCLUSION: This study revealed that the ON-Q pain management system is a more effective approach than IV PCA for acute postoperative surgical site pain relief after extended lower midline laparotomy in gynecologic cancer patients.
Amides
;
Analgesia
;
Analgesia, Patient-Controlled
;
Anesthesia, Local
;
Citric Acid
;
Female
;
Genital Neoplasms, Female
;
Gynecology
;
Humans
;
Infusions, Intravenous
;
Laparotomy
;
Pain Management
;
Pain, Postoperative
;
Passive Cutaneous Anaphylaxis
;
Perfusion
7.Regulation of paclitaxel-induced programmed cell death by autophagic induction: A model for cervical cancer.
Eun Young CHI ; Boonlert VIRIYAPAK ; Hyun Sung KWACK ; Yoon Kyung LEE ; Sang Il KIM ; Keun Ho LEE ; Tae Churl PARK
Obstetrics & Gynecology Science 2013;56(2):84-92
OBJECTIVE: Autophagy plays a vital role in homeostasis by combining organelles and cellular proteins with lysosome under starvation conditions. In addition, autophagy provides tumor cells with a source of energy. Continued autophagy will induce cells death. Here we aim to see if autophagic induction has an effect on conventional chemotherapeutic agents. METHODS: Rapamycin, or mammalian target of rapamycin and paclitaxel, apoptosis-inducing agents were used autophagy in HeLa cervical cancer cells. RESULTS: Growth inhibition of cells was not observed after the application of 0, 10, 20 nM of paclitaxel with or without rapamycin. Using a 5 nM concentration of paclitaxel, rapamycin administration inhibited cell growth significantly compared to no treatment. This implies the synergic antitumor effect of paclitaxel and rapamycin. Paclitaxel itself did not show any autophagic effect on cells but did show cell apoptosis by flow cytometry. Light chain 3, a microtubule-associated protein, which reflect autophagy, was increased with 5 nM of paclitaxel after pretreatment with 10 nM of rapamycin. CONCLUSION: These findings suggest that the autophagic inducer, rapamycin, can potentiate autophagic cell death when added as an apoptosis-inducing chemotherapeutic agent. In conclusion, the control of autophagy may be a future target for chemotherapy.
Apoptosis
;
Autophagy
;
Cell Death
;
Flow Cytometry
;
Homeostasis
;
Light
;
Lysosomes
;
Organelles
;
Paclitaxel
;
Proteins
;
Sirolimus
;
Starvation
;
TOR Serine-Threonine Kinases
;
Uterine Cervical Neoplasms
8.Clinicopathological significance of atypical glandular cells on Pap smear.
Sun Suk KIM ; Dong Soo SUH ; Ki Hyung KIM ; Man Soo YOON ; Kyung Un CHOI
Obstetrics & Gynecology Science 2013;56(2):76-83
OBJECTIVE: To investigate the clinical significance of atypical glandular cells (AGC) by analyzing the prevalence and histologic outcomes of patients with AGC according to Pap smear. METHODS: The medical records of 83 patients who were diagnosed AGC on Pap tests at the Pusan National University Hospital outpatient department and health care center from January 1998 to March 2006 were reviewed. RESULTS: The prevalence of AGC was 55 of 54,160 (0.10%) and 28 of 54,160 (0.05%) for AGC-not otherwise specified (NOS) and neoplastic associated AGC, respectively. The histopathologic results of the AGC-NOS group (n=55) were as follows: low-grade squamous intraepithelial lesion, 7 (12.7%); high-grade squamous intraepithelial lesion, 4 (7.2%); adenocarcinoma of cervix, 3 (5.4%); endometrial carcinoma, 2 (3.6%); and other malignancies including 2 ovarian cancer cases and 1 breast cancer case, 3 (5.4%). The histopathologic results for the AGC-associated neoplastic group (n=28) were as follows: low-grade squamous intraepithelial lesion, 1 (3.5%); high-grade squamous intraepithelial lesion, 3 (10.7%); adenocarcinoma of cervix, 5 (17.8%); endometrial carcinoma, 4 (4.8%); and additional malignancies including 3 stomach cancer cases, 2 ovarian cancer cases, and 2 breast cancer cases; 7 (25%). CONCLUSION: AGCs may represent a variety of benign and malignant lesions. AGC-associated neoplastic findings may be related to gynecological or extrauterine malignancies. Thus, when AGCs, especially neoplastic AGCs, are encountered, it is best to evaluate the cervix not only for typical maladies, but also for gynecological and non-gynecological malignancies.
Adenocarcinoma
;
Breast Neoplasms
;
Cervix Uteri
;
Delivery of Health Care
;
Endometrial Neoplasms
;
Female
;
Humans
;
Medical Records
;
Outpatients
;
Ovarian Neoplasms
;
Prevalence
;
Stomach Neoplasms
9.Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.
Obstetrics & Gynecology Science 2013;56(2):67-75
The levonorgestrel-releasing intrauterine system (LNG-IUS), originally designed for contraception, has since been applied to various gynecologic diseases. This article summarizes the current status of clinical applications of LNG-IUS to the treatment of gynecologic diseases such as heavy menstrual bleeding, endometriosis, leiomyoma, adenomyosis, endometrial hyperplasia, and early-stage endometrial cancer.
Adenomyosis
;
Contraception
;
Endometrial Hyperplasia
;
Endometrial Neoplasms
;
Endometriosis
;
Female
;
Genital Diseases, Female
;
Hemorrhage
;
Leiomyoma
;
Menorrhagia
10.Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood.
Ji Hyae LIM ; So Yeon PARK ; Hyun Mee RYU
Obstetrics & Gynecology Science 2013;56(2):58-66
Since the existence of cell-free fetal DNA (cff-DNA) in maternal circulation was discovered, it has been identified as a promising source of fetal genetic material in the development of reliable methods for non-invasive prenatal diagnosis (NIPD) of fetal trisomy 21 (T21). Currently, a prenatal diagnosis of fetal T21 is achieved through invasive techniques, such as chorionic villus sampling or amniocentesis. However, such invasive diagnostic tests are expensive, require expert technicians, and have a miscarriage risk approximately 1%. Therefore, NIPD using cff-DNA in the detection of fetal T21 is significant in prenatal care. Recently, the application of new techniques using single-molecular counting methods and the development of fetal-specific epigenetic markers has opened up new possibilities in the NIPD of fetal T21 using cff-DNA. These new technologies will facilitate safer, more sensitive and accurate prenatal tests in the near future. In this review, we investigate the recent methods for the NIPD of fetal T21 and discuss their implications in future clinical practice.
Abortion, Spontaneous
;
Amniocentesis
;
Chorionic Villi Sampling
;
Diagnostic Tests, Routine
;
DNA
;
Down Syndrome
;
Epigenomics
;
Female
;
Humans
;
Pregnancy
;
Prenatal Care
;
Prenatal Diagnosis
;
Trisomy